Systemic Manifestations of Rheumatic Diseases

Renal implications including glomerulonephritis, proteinuria, and renal failure in lupus and vasculitis

Rheumatic diseases such as lupus and vasculitis can lead to severe renal complications, including glomerulonephritis and kidney failure. Early diagnosis and effective management are crucial to mitigating kidney damage.

6/6/20257 min read25 views
loved it
normalintermediateGeneral Medicine
Renal Complications in Lupus and Vasculitis

Systemic Manifestations of Rheumatic Diseases: Renal Implications in Lupus and Vasculitis

Rheumatic diseases such as systemic lupus erythematosus (SLE) and vasculitis can have profound effects on renal function. These disorders often lead to complications such as glomerulonephritis, proteinuria, and ultimately renal failure, posing significant challenges in patient management.

Renal Manifestations of Lupus

Lupus nephritis, a serious complication of SLE, results from immune complex deposition in the glomeruli, leading to inflammation and progressive kidney damage. Clinical manifestations include:

  • Proteinuria: Indicative of glomerular dysfunction and frequently associated with nephrotic syndrome.
  • Hematuria: Due to glomerular inflammation and capillary damage.
  • Hypertension: Resulting from renal impairment and secondary hyperaldosteronism.

Renal Involvement in Vasculitis

Vasculitis, particularly ANCA-associated vasculitis (AAV), can lead to rapidly progressive glomerulonephritis. Major types include:

  • Granulomatosis with Polyangiitis (GPA): Affects small blood vessels leading to necrotizing glomerulonephritis.
  • Microscopic Polyangiitis (MPA): Associated with crescentic glomerulonephritis and renal dysfunction.
  • Eosinophilic Granulomatosis with Polyangiitis (EGPA): Less frequently impacts renal function but may cause interstitial nephritis.

Diagnosis and Management

Diagnosis typically involves:

  • Serologic tests (ANA, ANCA)
  • Urinalysis (proteinuria, hematuria assessment)
  • Renal biopsy (histopathologic confirmation)

Management strategies include immunosuppressive therapy with corticosteroids, cyclophosphamide, or mycophenolate mofetil, aimed at controlling inflammation and preventing progression to renal failure.

Tags

#Lupus nephritis#glomerulonephritis#vasculitis#ANCA-associated vasculitis#proteinuria#renal failure

0 people loved it

Recommended Reads

Explore related articles that might interest you

IgA Nephropathy
37
12%

IgA Nephropathy

Read more →
37
IgA Nephropathy
49
12%

IgA Nephropathy

Read more →
49
Chronic Renal Failure: Etiology, Pathogenesis, Pathology, Laboratory Findings, Progression, and Complications
27
11%

Chronic Renal Failure: Etiology, Pathogenesis, Pathology, Laboratory Findings, Progression, and Complications

Read more →
27
Urinary Abnormalities and Complications of Renal Diseases
24
11%

Urinary Abnormalities and Complications of Renal Diseases

Read more →
24
Urine analysis for the identification of normal and abnormal constituents
27
11%

Urine analysis for the identification of normal and abnormal constituents

Read more →
27
Systemic Manifestations of Rheumatic Diseases
33
11%

Systemic Manifestations of Rheumatic Diseases

Read more →
33
Urine analysis for the identification of normal and abnormal constituents
32
11%

Urine analysis for the identification of normal and abnormal constituents

Read more →
32
© 2025 MedGloss. All rights reserved.